Skip to main content

Jatenzo News

Testosterone Therapy Doesn't Increase Cancer Risk For Transmasculine People

FRIDAY, May 16, 2025 — Transmasculine and gender diverse people who use testosterone are not at an increased risk for cervical, ovarian or other gynecological cancers, a new study says. The results s...

FDA Medwatch Alert: FDA Alerts Customers to Voluntary Recall of Compounded Drugs Due to Sterility Issues by Drug Depot, LLC, dba APS Pharmacy

April 26, 2022 --FDA is alerting patients, health care professionals, veterinarians, and animal owners/caretakers about a voluntary recall by Drug Depot, LLC, doing business as APS Pharmacy, of...

FDA Approves Jatenzo (testosterone undecanoate) for Certain Forms of Hypogonadism

March 27, 2019 – The U.S. Food and Drug Administration today approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogonadism. These men have...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Hypogonadism - Male

Jatenzo patient information at Drugs.com